REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDODS.L Regulatory News (DODS)

  • There is currently no data for DODS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Placing

4 Sep 2006 07:32

Huveaux PLC04 September 2006 4 September 2006 HUVEAUX PLC Completion of the Placing of 11,827,957 new ordinary shares at 46.5 pence per share to raise £5.5 million Further to today's earlier announcement of the acquisition of Letts and Leckie,the Board of Huveaux PLC ("Huveaux") announces that it has completed the Placingof 11,827,957 new ordinary shares (the "New Ordinary Shares") at a price of 46.5pence per share to institutional investors, raising £5.5 million. For further information, please contact: Huveaux 020 7245 0270 John van Kuffeler, Executive Chairman Gerry Murray, Chief Executive Officer Dan O'Brien, Group Finance Director Dresdner Kleinwort 020 7623 8000 Charles Batten Joe Thompson Bell Lawrie 0141 314 8108 Iain Macarthur Finsbury 020 7251 3801 James Leviton This announcement has been prepared solely to provide information about the Placing and it does not constitute, or form part of, any offer or invitation to purchase, underwrite or otherwise acquire New Ordinary Shares being offered, or the solicitation of any such offer. Without limiting the foregoing statement, this announcement does not constitute an offer of securities for sale in the United States nor the solicitation of an offer to buy any such securities, nor may securities be offered or sold in the United States absent registration or anexemption from registration as provided in the United States Securities Act of 1933, as amended (the "Securities Act"), and the rules and regulations thereunder. Huveaux does not intend to register the New Ordinary Shares under the Securities Act. This announcement does not constitute an offer to sell or issue or a solicitation of an offer to buy or subscribe for New Ordinary Shares in any jurisdiction including, without limitation, Canada, Australia, Japan or any other jurisdiction in which such offer or solicitation is or may be unlawful.This announcement and the information contained herein are not for publication or distribution, directly or indirectly, to persons in Canada, Australia or Japan unless permitted pursuant to an exemption under the relevant local law orin any jurisdiction in which such publication or distribution is unlawful. Dresdner Kleinwort Wasserstein Limited and Dresdner Bank AG, London Branch, which are authorised and regulated by the Financial Services Authority, are acting for Huveaux and for no one else in connection with the Placing and will not be responsible to anyone other than Huveaux for providing the protections afforded to the customers of Dresdner Kleinwort Wasserstein Limited and DresdnerBank AG, London Branch or for affording advice in relation to the Placing, or any other matters referred to herein. This statement should not be interpreted to mean that future earnings per share of Huveaux will necessarily be greater than those of previous periods. No representation or warranty, express or implied, is made by Dresdner Kleinwortas to any of the contents of this announcement for which the directors of Huveaux are solely responsible. This announcement contains certain forward-looking statements. Such forward-looking statements are based on currentplans, information and intentions and certain external factors which may be beyond the control of Huveaux, and therefore, undue reliance should not be placed on them. Such forward-looking statements involve unknown risks, uncertainties and other factors which may cause the actual results, financial condition, performance or achievements of Huveaux, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements speak only as to the date on which they are made and Huveaux undertakes no obligation to update publicly any such forward-looking statements in this announcement to reflect future events or developments. Note to Editors: • Huveaux Huveaux was formed in 2001 with the objective of building a substantial,high-quality publishing and media group. It is now twenty fold the size when itfirst listed on AIM. The Group consists of three Divisions each of which has strong brands andmarket-leading positions: Political Division comprises Dod's Parliamentary Companion, The House Magazine,Epolitix.com, Political Wizard and numerous other magazine titles andrevenue-generating websites. It is the market leader in Politicalbusiness-to-business publishing in the UK and the EU. Learning Division comprises Epic, the UK market leader in e-learning; TheTraining Journal magazine and seminar business; Lonsdale Revision Guides forschools and the highly acclaimed Westminster Explained conferences and seminars. Healthcare Division based in France, comprises Panorama du Medecin, a leadingweekly magazine for French doctors; Le Concours Medical and La Revue duPraticien, both market-leading Continuing Medical Education magazines; Egora.fr,the leading medical information website; and a number of other magazines and amedical conference business. Huveaux has now completed ten successful acquisitions over the past four yearsand employs more than 450 staff in London, Paris, Brussels and four UK regionaloffices. Further information about Huveaux can be found at www.huveauxplc.com The name Huveaux is a trademark of Huveaux PLC. All other trademarks mentionedherein are the property of Huveaux's respective subsidiary companies. All rightsreserved. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Apr 20214:05 pmRNSHolding(s) in Company
16th Apr 202111:30 amRNSResult of General Meeting
1st Apr 20217:00 amRNSPosting of Circular and Notice of GM
30th Mar 20217:01 amRNSChange of Name and Share Capital Reorganisation
30th Mar 20217:00 amRNSTrading Update
30th Nov 20207:00 amRNSHalf-year Report
26th Nov 202011:35 amRNSBoard Changes
12th Oct 20204:23 pmRNSHolding(s) in Company
29th Sep 202012:21 pmRNSResult of AGM
4th Sep 202012:31 pmRNSAnnual Financial Report
3rd Sep 20207:02 amRNSFinal Results
3rd Sep 20207:00 amRNSAppointment of Nominated Adviser and Sole Broker
5th Aug 20202:02 pmRNSHolding(s) in Company
29th Jul 20207:00 amRNSIssue of Shares and Director / PDMR Dealing
1st Jul 202010:52 amRNSDirectorate Change
18th Jun 20207:00 amRNSDr David Hammond
1st Jun 20202:06 pmRNSBoard Appointments
1st Jun 20207:00 amRNSUpdated Debt Facilities
23rd Apr 20207:06 amRNSAppointment of CFO and COVID-19 Update
18th Mar 20205:46 pmRNSAIM Rule 17 Notification
24th Feb 20203:47 pmRNSDirectorate Change
22nd Jan 20202:52 pmRNSDirectorate Change
22nd Jan 20207:00 amRNSTrading Update
29th Oct 20197:00 amRNSHalf-year Report
26th Sep 20197:00 amRNSChange of Adviser
25th Sep 20198:59 amRNSAIM Rule 17 Schedule Two (g) Update
2nd Sep 20197:00 amRNSDirectorate Change
29th Aug 20194:07 pmRNSResult of AGM
23rd Jul 20197:00 amRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20191:42 pmRNSCompletion of Acquisition
18th Jul 20198:48 amRNSDirector/PDMR Shareholding
18th Jul 20198:46 amRNSAnnual Financial Report
16th Jul 201910:39 amRNSResult of General Meeting and Open Offer
28th Jun 20198:47 amRNSGeneral Meeting & Open Offer Timetable
28th Jun 20197:00 amRNSAcquisition, Fundraising and Notice of GM
28th Jun 20197:00 amRNSFinal Results
11th Jun 20197:00 amRNSAcquisition of Meritgroup
10th Jun 20197:00 amRNSResponse re. Press Speculation
21st May 20197:00 amRNSAppointment of Chief Revenue Officer
29th Apr 20197:00 amRNSAppointment of Chief Information Officer
21st Jan 20197:00 amRNSTrading Statement
5th Dec 20181:50 pmRNSHolding(s) in Company
5th Dec 20181:50 pmRNSHolding(s) in Company
14th Nov 20187:00 amRNSHalf-year Report
21st Sep 201811:17 amRNSLong Term Incentive Plan
14th Aug 201812:39 pmRNSDirectorate Change
7th Aug 20184:14 pmRNSDirector/PDMR Shareholding
1st Aug 20189:52 amRNSDirectorate Change
1st Aug 20189:24 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.